JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for EVIDENCE-BASED-HEALTH Archives


EVIDENCE-BASED-HEALTH Archives

EVIDENCE-BASED-HEALTH Archives


EVIDENCE-BASED-HEALTH@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

EVIDENCE-BASED-HEALTH Home

EVIDENCE-BASED-HEALTH Home

EVIDENCE-BASED-HEALTH  February 2011

EVIDENCE-BASED-HEALTH February 2011

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Re: Question about screening and denominators

From:

Roger Kerry <[log in to unmask]>

Reply-To:

Roger Kerry <[log in to unmask]>

Date:

Thu, 10 Feb 2011 17:39:42 +0000

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (183 lines)

and I think that this would be the 'long-hand' Bayesian proof (I have assumed a high sensitivity as an example):

if,
•	Sensitivity 98% (i.e. a FN rate of 2%)
•	Specificity 95% (i.e. a FP rate of 5%)
•	Prevalence = 1:1000

and let,

•	A be the event that a patient truly has disease.
•	¬A be the event they  truly don’t have the disease
•	B be the event that they test positive.

Our question is: 

“What is the chance the patient testing positive actually has the diseaseI?”

Expressed in Bayesian form, this is p(A/B) i.e. 

“what is the probability of the patient truly having the disease given the event that they test positive?”

So,
“98% sensitivity” means that p(B/A) = .98
“95% specificity” means that p(B/ ¬A) = .05

Using Bayes theorem:

p(A/B) =  _____p(B/A)p(A)______
	     p(B/A)p(A) + p(B/¬A )p(¬A)
thus:

p(A/B) = _____.98x.001_______   =  0.0192 (i.e. 1.9%)
	      .98x.001 + .05x.999

I think this is correct. Apologies if the formula de-formats.

Best 
Roger


Roger Kerry FMACP MSc MCSP
Associate Professor
Division of Physiotherapy Education
University of Nottingham
United Kingdom


________________________________________
From: Evidence based health (EBH) [[log in to unmask]] On Behalf Of Pasquale Urbano [[log in to unmask]]
Sent: Thursday, February 10, 2011 4:31 PM
To: [log in to unmask]
Subject: R: Question about screening and denominators

Click on http://araw.mede.uic.edu/cgi-alansz/testcalc.pl?DT=95&Dt=5&dT=4995&dt=94905&2x2=Compute and see what happens with your numbers: the pre-test probability [prevalence, if you have no other info: 1/1000], increases 19fold to the post test probability of about 2/100; a negative result will rule out the desease with confidence.
To screen for rare diseases you better use the most sensitive test available [>99% ?], followed by the most specific, to rule out the false positives.

___________________________________________________________________
Prof. Pasquale Urbano
Ordinario di Microbiologia, F.R.
Dipartimento di Sanità Pubblica,
Università di Firenze


Da: Evidence based health (EBH) [mailto:[log in to unmask]] Per conto di Simon Hatcher
Inviato: giovedì 10 febbraio 2011 11.34
A: [log in to unmask]
Oggetto: Re: Question about screening and denominators

After another night this time on the red wine my friend has provided me with the source of the problem - it is John Lanchester's book "Whoops" where Lanchester writes "if a test for some disease is 95% accurate, and the disease affects one person in a thousand, and you go for a test and it comes back positive, what's the probability that you have the disease? Most respondents say, well the test is accurate, so the probability is 95%. The correct answer is 2%, because if you test 1000 people, the test will give fifty positives, whereas only one of the population has the illness". The reference for this is Nassim Nicholas Taleb's "Fooled by Randomness". Is he right?

________________________________
From: Evidence based health (EBH) on behalf of Miranda Cumpston (Med)
Sent: Thu 10/02/2011 13:08
To: [log in to unmask]
Subject: Re: Question about screening and denominators
Hi all,

Just for the sake of it, here are some numbers, assuming that you mean 95% for both specificity and sensitivity (which is a pretty unlikely test) – that is, the test will detect 95% of true positives and true negatives (using a population of 100,000 to keep everything in whole numbers):



True +

True -

Total

Test +

               95

               4,995

              5,090

Test -

                 5

             94,905

           94,910

Total

            100

             99,900

         100,000


So, assuming you have a positive test (i.e. you’re in the top row), then the probability that you actually have the disease is only 95/5090,  or about 2%, even with a pretty good test. The reason is that the sheer number of people without the disease is so much greater that even a low % of false positives translates into large absolute numbers.

For rare diseases, tests are often much better at ruling out disease than ruling it in. If you had tested negative, your probability of having the disease would be 5/94,910, or 0.0001%.

Hope that’s right – would be a shame to get it wrong in front of such an audience : ). And of course, if you mean something else by “correctly detects the disease”, then you’d have to adjust the numbers accordingly.

cheers,
Miranda


From: Evidence based health (EBH) [mailto:[log in to unmask]<mailto:[log in to unmask]>] On Behalf Of Paul Glasziou
Sent: Thursday, 10 February 2011 10:55 AM
To: [log in to unmask]<mailto:[log in to unmask]>
Subject: Re: Question about screening and denominators

Hi Simon,
Brian is right that you need to know more to answer the question.
If the "test which correctly detects the disease 95%of the time" and we interpret that as the sensitivity.
If the specificity is 5% then the test is useless - a Youden index (sensitivity + specicity - 100%)
and so after a positive test the chance of disease is still 1:1000
Paul Glasziou
PS If instead the 95% is the overall accuracy, then just call everyone negative and the test is 99.9% accurate ;-)


On 2/10/2011 9:31 AM, Brian Alper MD wrote:
Here’s my quick thoughts without doing any math or providing formulas.

More than one answer is possible depending on how one interprets “correctly detects the disease 95% of the time”

If you know the sensitivity (% correct in patients with known disease), specificity (% correct in patients known to not have disease) and disease prevalence (1:1000 in this example) you can answer the question.

But overall measures of diagnostic accuracy (% correct overall based on combining sensitivity and specificity) could reach 95% through different combinations of sensitivity and specificity.  The different combinations could lead to different results for your question (a measure of positive predictive value)

Brian S. Alper, MD, MSPH
Editor-in-Chief, DynaMed (www.ebscohost.com/dynamed<http://www.ebscohost.com/dynamed>)

From: Evidence based health (EBH) [mailto:[log in to unmask]] On Behalf Of Simon Hatcher
Sent: Wednesday, February 09, 2011 6:22 PM
To: [log in to unmask]<mailto:[log in to unmask]>
Subject: Question about screening and denominators

I had this discussion with a friend over a beer last night and we couldn't agree on the answer. Here's the scenario:

The incidence of a disease in a population is 1:1000
There is a test which correctly detects the disease 95%of the time
If I test positive with the test what is my risk of having the disease?

Be interested in any thoughts on the "correct" answer.

Cheers

Simon





--

Paul Glasziou

Bond University

Qld, Australia 4229

This message and any attachment are intended solely for the addressee and may contain confidential information. If you have received this message in error, please send it back to me, and immediately delete it.   Please do not use, copy or disclose the information contained in this message or in any attachment.  Any views or opinions expressed by the author of this email do not necessarily reflect the views of the University of Nottingham.



This message has been checked for viruses but the contents of an attachment

may still contain software viruses which could damage your computer system:

you are advised to perform your own checks. Email communications with the

University of Nottingham may be monitored as permitted by UK legislation.

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
December 2004
November 2004
October 2004
September 2004
August 2004
July 2004
June 2004
May 2004
April 2004
March 2004
February 2004
January 2004
December 2003
November 2003
October 2003
September 2003
August 2003
July 2003
June 2003
May 2003
April 2003
March 2003
February 2003
January 2003
December 2002
November 2002
October 2002
September 2002
August 2002
July 2002
June 2002
May 2002
April 2002
March 2002
February 2002
January 2002
December 2001
November 2001
October 2001
September 2001
August 2001
July 2001
June 2001
May 2001
April 2001
March 2001
February 2001
January 2001
December 2000
November 2000
October 2000
September 2000
August 2000
July 2000
June 2000
May 2000
April 2000
March 2000
February 2000
January 2000
December 1999
November 1999
October 1999
September 1999
August 1999
July 1999
June 1999
May 1999
April 1999
March 1999
February 1999
January 1999
December 1998
November 1998
October 1998
September 1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager